{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:13:46Z","timestamp":1790439226807,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"10","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>To compare the deoxyribonucleic acid (DNA) methylation signature of neuroendocrine tumors (NETs) by primary tumor site and inherited predisposition syndromes von Hippel\u2013Lindau disease (VHL) and multiple endocrine neoplasia type 1 (MEN1).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Genome-wide DNA methylation (835 424 CpGs) of 96 NET samples. Principal components analysis (PCA) and unsupervised hierarchical clustering analyses were used to determine DNA methylome signatures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Hypomethylated CpGs were significantly more common in VHL-related versus sporadic and MEN1-related NETs (P &amp;lt; .001 for both comparisons). Small-intestinal NETs (SINETs) had the most differentially methylated CpGs, either hyper- or hypomethylated, followed by duodenal NETs (DNETs) and pancreatic NETs (PNETs, P &amp;lt; .001 for all comparisons). There was complete separation of SINETs on PCA, and 3 NETs of unknown origin clustered with the SINET samples. Sporadic, VHL-related, and MEN1-related PNETs formed distinct groups on PCA, and VHL clustered separately, showing pronounced DNA hypomethylation, while sporadic and MEN1-related NETs clustered together. MEN1-related PNETs, DNETs, and gastric NETs each had a distinct DNA methylome signature, with complete separation by PCA and unsupervised clustering. Finally, we identified 12 hypermethylated CpGs in the 1A promoter of the APC (adenomatous polyposis coli) gene, with higher methylation levels in MEN1-related NETs versus VHL-related and sporadic NETs (P &amp;lt; .001 for both comparisons).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>DNA CpG methylation profiles are unique in different primary NET types even when occurring in MEN1-related NETs. This tumor DNA methylome signature may be utilized for noninvasive molecular characterization of NETs, through DNA methylation profiling of biopsy samples or even circulating tumor DNA in the near future.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa477","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T17:17:01Z","timestamp":1595611021000},"page":"3285-3294","source":"Crossref","is-referenced-by-count":21,"title":["Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-9634","authenticated-orcid":false,"given":"Amit","family":"Tirosh","sequence":"first","affiliation":[{"name":"Endocrine Oncology Bioinformatics Lab and NET Service, Endocrine Institute, Chaim Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Keith","family":"Killian","sequence":"additional","affiliation":[{"name":"Genetics, National Cancer Institute, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Petersen","sequence":"additional","affiliation":[{"name":"Genetics, National Cancer Institute, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin Jack","family":"Zhu","sequence":"additional","affiliation":[{"name":"Genetics, National Cancer Institute, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Walker","sequence":"additional","affiliation":[{"name":"Genetics, National Cancer Institute, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E","family":"Blau","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branches, National Cancer Institute, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Patel","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branches, National Cancer Institute, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita K","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Scott","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Meltzer","sequence":"additional","affiliation":[{"name":"Genetics, National Cancer Institute, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[{"name":"Department of Surgery and Stanford Cancer Institute, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"issue":"10","key":"2021122105533567700_CIT0001","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"issue":"4","key":"2021122105533567700_CIT0002","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000494355","article-title":"Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: data from a large international cohort study","volume":"107","author":"Rindi","year":"2018","journal-title":"Neuroendocrinology."},{"issue":"2","key":"2021122105533567700_CIT0003","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS Consensus Guidelines Update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology."},{"issue":"2","key":"2021122105533567700_CIT0004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology."},{"key":"2021122105533567700_CIT0005","doi-asserted-by":"crossref","DOI":"10.1159\/000464292","article-title":"ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours","author":"Partelli","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"8","key":"2021122105533567700_CIT0006","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","article-title":"Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids","volume":"26","author":"Caplin","year":"2015","journal-title":"Ann Oncol."},{"issue":"4","key":"2021122105533567700_CIT0007","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamaoncol.2018.6720","article-title":"Therapeutic options for neuroendocrine tumors: a systematic review and network meta-analysis","volume":"5","author":"Kaderli","year":"2019","journal-title":"JAMA Oncol."},{"issue":"5","key":"2021122105533567700_CIT0008","doi-asserted-by":"crossref","first-page":"e008248","DOI":"10.1136\/bmjopen-2015-008248","article-title":"Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial","volume":"5","author":"Neychev","year":"2015","journal-title":"BMJ Open."},{"key":"2021122105533567700_CIT0009","first-page":"6424812","article-title":"Management options for advanced low or intermediate grade gastroenteropancreatic neuroendocrine tumors: review of recent literature","volume":"2017","author":"Neychev","year":"2017","journal-title":"Int J Surg Oncol."},{"issue":"12","key":"2021122105533567700_CIT0010","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet."},{"issue":"1","key":"2021122105533567700_CIT0011","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res."},{"issue":"7643","key":"2021122105533567700_CIT0012","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature."},{"issue":"1","key":"2021122105533567700_CIT0013","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JME-18-0050","article-title":"Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types","volume":"61","author":"Iyer","year":"2018","journal-title":"J Mol Endocrinol."},{"issue":"8","key":"2021122105533567700_CIT0014","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/cncr.31930","article-title":"Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors","volume":"125","author":"Tirosh","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"2021122105533567700_CIT0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41591-018-0323-0","article-title":"Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions","volume":"25","author":"Teixeira","year":"2019","journal-title":"Nat Med."},{"key":"2021122105533567700_CIT0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-60327-216-2_8","article-title":"Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples","volume":"823","author":"Killian","year":"2012","journal-title":"Methods Mol Biol."},{"issue":"6","key":"2021122105533567700_CIT0017","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","article-title":"Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor","volume":"3","author":"Killian","year":"2013","journal-title":"Cancer Discov."},{"issue":"10","key":"2021122105533567700_CIT0018","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays","volume":"30","author":"Aryee","year":"2014","journal-title":"Bioinformatics."},{"issue":"24","key":"2021122105533567700_CIT0019","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","article-title":"ChAMP: updated methylation analysis pipeline for Illumina BeadChips","volume":"33","author":"Tian","year":"2017","journal-title":"Bioinformatics."},{"key":"2021122105533567700_CIT0020","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Whickham","year":"2016"},{"issue":"11","key":"2021122105533567700_CIT0021","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/bioinformatics\/bty892","article-title":"methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing","volume":"35","author":"Ren","year":"2019","journal-title":"Bioinformatics."},{"key":"2021122105533567700_CIT0022","author":"Tirosh","year":"2020"},{"key":"2021122105533567700_CIT0023","article-title":"Distinct DNA methylation signatures in neuroendocrine tumors specific for primary site and inherited predisposition","author":"Tirosh","journal-title":"Dryad"},{"issue":"6021","key":"2021122105533567700_CIT0024","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science."},{"issue":"3","key":"2021122105533567700_CIT0025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cncr.31057","article-title":"Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype","volume":"124","author":"Keutgen","year":"2018","journal-title":"Cancer."},{"issue":"8","key":"2021122105533567700_CIT0026","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/ijc.30565","article-title":"Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients","volume":"140","author":"Bedin","year":"2017","journal-title":"Int J Cancer."},{"issue":"9","key":"2021122105533567700_CIT0027","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/15592294.2017.1356957","article-title":"Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples","volume":"12","author":"Bart\u00e1k","year":"2017","journal-title":"Epigenetics."},{"issue":"11","key":"2021122105533567700_CIT0028","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1136\/gutjnl-2016-313372","article-title":"Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer","volume":"67","author":"Barault","year":"2018","journal-title":"Gut."},{"key":"2021122105533567700_CIT0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13148-016-0282-6","article-title":"Blood-based DNA methylation as biomarker for breast cancer: a systematic review","volume":"8","author":"Tang","year":"2016","journal-title":"Clin Epigenetics."},{"issue":"13","key":"2021122105533567700_CIT0030","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/1078-0432.CCR-10-3436","article-title":"An epigenetic marker panel for detection of lung cancer using cell-free serum DNA","volume":"17","author":"Begum","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"8","key":"2021122105533567700_CIT0031","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/cncr.22190","article-title":"Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion","volume":"107","author":"Benlloch","year":"2006","journal-title":"Cancer."},{"issue":"1","key":"2021122105533567700_CIT0032","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13059-017-1191-5","article-title":"CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA","volume":"18","author":"Kang","year":"2017","journal-title":"Genome Biol."},{"issue":"11","key":"2021122105533567700_CIT0033","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.18632\/oncotarget.7279","article-title":"Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget."},{"issue":"1","key":"2021122105533567700_CIT0034","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2018.07.040","article-title":"Identification of ICAT as an APC inhibitor, revealing Wnt-dependent inhibition of APC-axin interaction","volume":"72","author":"Ji","year":"2018","journal-title":"Mol Cell."},{"key":"2021122105533567700_CIT0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13578-015-0013-2","article-title":"Association of aberrant DNA methylation in Apc(min\/+) mice with the epithelial-mesenchymal transition and Wnt\/\u03b2-catenin pathways: genome-wide analysis using MeDIP-seq","author":"Guo","year":"2015","journal-title":"Cell Biosci."},{"issue":"10","key":"2021122105533567700_CIT0036","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ijc.22569","article-title":"Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system","volume":"120","author":"Arnold","year":"2007","journal-title":"Int J Cancer."},{"key":"2021122105533567700_CIT0037","first-page":"423","article-title":"Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms","volume":"238","author":"House","year":"2003","journal-title":"Trans. Meet. Am. Surg. Assoc."},{"issue":"5","key":"2021122105533567700_CIT0038","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ajhg.2016.03.001","article-title":"Point mutations in exon 1B of APC Reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant","volume":"98","author":"Li","year":"2016","journal-title":"Am J Hum Genet."},{"issue":"6","key":"2021122105533567700_CIT0039","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s10120-018-0855-5","article-title":"First report of an Asian family with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) revealed with the germline mutation of the APC exon 1B promoter region","volume":"21","author":"Mitsui","year":"2018","journal-title":"Gastric Cancer."},{"issue":"6","key":"2021122105533567700_CIT0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10 000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa477\/33565418\/dgaa477.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/10\/3285\/41828171\/dgaa477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/10\/3285\/41828171\/dgaa477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T05:55:39Z","timestamp":1640066139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/10\/3285\/5876017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,7,24]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa477","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,7,24]]}}}